This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Cincinnati Children's Hospital Medical Center. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Kana Mizuno: Innovator in Complement Inhibition
Introduction
Kana Mizuno is a notable inventor based in Cincinnati, OH, who has made significant contributions to the field of medical treatment through his innovative patent. His work focuses on addressing disorders characterized by complement system dysregulation, which can have profound implications for patient care.
Latest Patents
Kana Mizuno holds a patent for a "Dosing algorithm for complement inhibitor." This patent describes methods and systems designed for the treatment of individuals suffering from disorders related to complement system dysregulation. The innovative methods outlined in the patent can be utilized for various purposes, including establishing personalized dosing schedules for complement inhibitors, maintaining effective dosage levels, and identifying treatment regimens that minimize the risk of underdosing or toxicity in patients.
Career Highlights
Kana Mizuno is affiliated with Cincinnati Children's Hospital Medical Center, where he applies his expertise in developing treatment methodologies that enhance patient outcomes. His dedication to improving medical practices through innovation is evident in his patent and ongoing research efforts.
Collaborations
Kana collaborates with esteemed colleagues, including Tsuyoshi Fukuda and Sonata Jodele, who contribute to the advancement of research in the field of complement inhibition and related medical treatments.
Conclusion
Kana Mizuno's work exemplifies the impact of innovative thinking in the medical field, particularly in the treatment of complex disorders. His contributions through patenting a dosing algorithm for complement inhibitors highlight the importance of personalized medicine in enhancing patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
